SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Alcohol-Related Disorders D019973 3 associated lipids
Lead Poisoning D007855 4 associated lipids
Urinary Incontinence D014549 4 associated lipids
Dyspepsia D004415 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Amnesia D000647 12 associated lipids
Glucose Intolerance D018149 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Brain Infarction D020520 17 associated lipids
Angina Pectoris D000787 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometriosis D004715 29 associated lipids
Stroke D020521 32 associated lipids
Memory Disorders D008569 33 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Cataract D002386 34 associated lipids
Burns D002056 34 associated lipids
Fever D005334 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Heart Failure D006333 36 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Arthritis D001168 41 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Fatty Liver D005234 48 associated lipids
Parkinson Disease D010300 53 associated lipids
Reperfusion Injury D015427 65 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Coronary Disease D003327 70 associated lipids
Alzheimer Disease D000544 76 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Zhou PQ et al. [Clinical observation of puerarin in treating patients with vertebral artery insufficiency due to cervical spondylosis: a report of 123 cases]. 2006 Zhong Xi Yi Jie He Xue Bao pmid:16409979
Xiong FL et al. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. 2006 Eur. J. Pharmacol. pmid:16321378
Yan B et al. Determination of puerarin in rat cortex by high-performance liquid chromatography after intravenous administration of Puerariae flavonoids. 2006 Biomed. Chromatogr. pmid:16078309
Yu Z and Li W Induction of apoptosis by puerarin in colon cancer HT-29 cells. 2006 Cancer Lett. pmid:16055262
Li L and Zhang CR Production of puerarin and isoflavones in cell suspension cultures of Pueraria lobata (Willd.): effects of medium supplementation with casein hydrolysate and coconut milk. 2006 J Environ Biol pmid:16850870
Wang Q et al. Puerarin injection for unstable angina pectoris. 2006 Cochrane Database Syst Rev pmid:16856037
Zhang S et al. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. 2006 J. Nutr. Biochem. pmid:16426832
Weiping S et al. Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin. 2006 Colloids Surf B Biointerfaces pmid:16466908
Yan LP et al. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. 2006 Life Sci. pmid:16472823
Yu AH et al. [Preparation of puerarin solid self-microemulsion]. 2006 Zhong Yao Cai pmid:17076244
Qi H et al. Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use. 2006 Chem. Pharm. Bull. pmid:17077546
Wu CJ et al. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro. 2006 Pharmazie pmid:17020156
Yeung DK et al. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. 2006 Eur. J. Pharmacol. pmid:17027964
Chen L et al. Simultaneous analysis of nine active components in Gegen Qinlian preparations by high-performance liquid chromatography with diode array detection. 2006 J Sep Sci pmid:17069251
Kim JM et al. Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs). 2006 Arch. Pharm. Res. pmid:17121174
Wang C et al. [Therapeutic effect of puerarin on rats with pre-eclampsia]. 2006 Zhonghua Fu Chan Ke Za Zhi pmid:16640862
Yu Z et al. Simultaneous determination of components in preparation Naodesheng injection by high performance liquid chromatograph-atmospheric pressure chemical ionization mass spectrometry (HPLC-MS/APCI). 2006 Chem. Pharm. Bull. pmid:16595973
Wu XP et al. [Protective effects of puerarin against myocardial injury in patients with hypertension during perioperational period]. 2006 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:16613276
Zhang B et al. [Protective effects of hydroxyethylpuerarin against brain astrocytes injury induced by hydrogen peroxide]. 2006 Yao Xue Xue Bao pmid:16671550
Xu YZ et al. [Effects of puerarin on proliferation of vascular smooth muscle cells induced by thrombin]. 2006 Zhonghua Yi Xue Za Zhi pmid:16677576
Xu YZ et al. [Puerarin suppresses the proliferation of vscular smooth muscule cells and c-fos and bcl-2 protein expression]. 2006 Zhongguo Zhong Yao Za Zhi pmid:16722382
Wang FW et al. [Protective effect of puerarin on stress-induced gastric mucosal injury in rats]. 2006 Zhongguo Zhong Yao Za Zhi pmid:16722386
Hao LN et al. Puerarin decreases lens epithelium cell apoptosis induced partly by peroxynitrite in diabetic rats. 2006 Sheng Li Xue Bao pmid:17173194
Li JX et al. [Effect of puerarin on ADMA-DDAH system in human umbilical vein endothelial cells cultured with oxidized free radical]. 2006 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:17205823
Kirakosyan A et al. Regulation of isoflavone production in hydroponically grown Pueraria montana (kudzu) by cork pieces, XAD-4, and methyl jasmonate. 2006 Plant Cell Rep. pmid:16841218
Gao Q et al. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart. 2006 Life Sci. pmid:16458326
Deng X et al. [Pharmacokinetics of puerarin in the aqueous humor and vitreous of rabbit eye following systemic administration]. 2006 Yan Ke Xue Bao pmid:17378162
Li DZ et al. [Protective effect of puerarin on endothelial dysfunction of heat shock protein 60 induced specific immunity in apolipoprotein E-null mice]. 2006 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:17569333
Chen SB et al. High-performance thin-layer chromatographic fingerprints of isoflavonoids for distinguishing between Radix Puerariae Lobate and Radix Puerariae Thomsonii. 2006 J Chromatogr A pmid:16714027
Delmonte P et al. Determination of isoflavones in dietary supplements containing soy, Red Clover and kudzu: extraction followed by basic or acid hydrolysis. 2006 J Chromatogr A pmid:16413562
Kirakosyan A et al. Isoflavone levels in five soybean (Glycine max) genotypes are altered by phytochrome-mediated light treatments. 2006 J. Agric. Food Chem. pmid:16390177
Zhang SP et al. [The experimental study of Radix Puerariae inhibiting glycation in rats induced by D-galactose]. 2006 Zhong Yao Cai pmid:16850728
Lv JH et al. [Improvement effects of puerarin on glycated brain damages in rats induced by D-galactose]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17048591
Pan HP et al. [Protection of puerarin on the cerebral injury in the rats with acute local ischemia]. 2005 Zhongguo Zhong Yao Za Zhi pmid:15810455
Cui S et al. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry. 2005 Biomed. Chromatogr. pmid:15627278
Li C et al. Non-aqueous capillary electrophoresis for simultaneous separation and determination of three major active components in traditional medicinal preparations. 2005 Biomed. Chromatogr. pmid:15627280
Jin LH et al. [Protective effects of puerarin on radiation injury of experimental rats]. 2005 Zhong Xi Yi Jie He Xue Bao pmid:15644160
Feng CG et al. [Progress in research of aldose reductase inhibitors in traditional medicinal herbs]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16335816
Cui S et al. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone. 2005 Drug Dev Ind Pharm pmid:16093200
Mao CP and Gu ZL Puerarin reduces increased c-fos, c-jun, and type IV collagen expression caused by high glucose in glomerular mesangial cells. 2005 Acta Pharmacol. Sin. pmid:16038632
Xu X et al. The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. 2005 Planta Med. pmid:16041641
Li C et al. Separation and simultaneous determination of rutin, puerarin, daidzein, esculin and esculetin in medicinal preparations by non-aqueous capillary. 2005 J Pharm Biomed Anal pmid:15894450
Xiao LZ et al. [Comparative study on effects of puerarin and granulocyte colony-stimulating factor in treating acute myocardial infarction]. 2005 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:15842138
Xu ME et al. The study of anti-metabolic syndrome effect of puerarin in vitro. 2005 Life Sci. pmid:16005472
Ma Z et al. Determination of puerarin in human plasma by high performance liquid chromatography. 2005 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16009605
Pan HP et al. [Effect of puerarin on the expression of Hsp70 in the rats with cerebral injury induced by acute local ischemia]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16011103
Zhao Y et al. [Experimental study of protective effect of pueraria compound on the cerebral ischemic injury]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16011106
Gao Q et al. Improvement of ventricular mechanical properties by puerarin involves mitochondrial permeability transition in isolated rat heart during ischemia and reperfusion. 2005 Conf Proc IEEE Eng Med Biol Soc pmid:17281523
Plontke S Therapy of hearing disorders - conservative procedures. 2005 GMS Curr Top Otorhinolaryngol Head Neck Surg pmid:22073049
Zhang S et al. Application of microdialysis technique in the traditional chinese medicine. 2005 Conf Proc IEEE Eng Med Biol Soc pmid:17282072